Aledade Stock

aledade.comHealthcare / Healthcare providers & servicesFounded: 2014Funding to Date: $696.82MM

Aledade is a healthcare company that partners with independent, primary care physicians to provide everything the doctors need to create and run an Accountable Care Organization (ACO) – from business and practice transformation services to upfront capital and a cutting-edge technology platform.

Register To Buy and Sell Private Company Shares

For more details on private stock price information, financing and valuation for Aledade, register or login.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Private Market Pricing DetailsValuation & Financings

Aledade Stock Price

Forge Price 1
Price not yet available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Aledade Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
06/21/2023 Series F $260MM $xx.xx $3.52B Lightspeed Venture Partners, Venrock, Avidity Partners, OMERS Growth Equity, Fidelity
Price per Share
$xx.xx
Shares Outstanding
5,187,804
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Lightspeed Venture Partners, Venrock, Avidity Partners, OMERS Growth Equity, Fidelity
06/06/2022 Series E-3 $30MM $xx.xx $3.14B OMERS Growth Equity, Fidelity
Price per Share
$xx.xx
Shares Outstanding
602,235
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMERS Growth Equity, Fidelity
06/06/2022 Series E-2 $10.29MM $xx.xx $3.14B OMERS Growth Equity, Fidelity
Price per Share
$xx.xx
Shares Outstanding
242,984
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMERS Growth Equity, Fidelity
06/06/2022 Series E-1 $92.27MM $xx.xx $3.14B OMERS Growth Equity, Fidelity
Price per Share
$xx.xx
Shares Outstanding
1,852,227
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMERS Growth Equity, Fidelity
01/19/2021 Series D $100.25MM $xx.xx $2.37B Meritech Capital Partners, Tiger Global Management, IVP, OMERS Growth Equity
Price per Share
$xx.xx
Shares Outstanding
2,618,130
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Meritech Capital Partners, Tiger Global Management, IVP, OMERS Growth Equity
04/20/2020 Series C $67.33MM $xx.xx $735.89MM OMERS Growth Equity, California Medical Association, Meritech Capital Partners, Echo Health Ventures, CVF, GV
Price per Share
$xx.xx
Shares Outstanding
5,206,094
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMERS Growth Equity, California Medical Association, Meritech Capital Partners, Echo Health Ventures, CVF, GV
01/18/2019 Series B-2 $56.15MM $xx.xx $411.08MM Echo Health Ventures, Meritech Capital Partners
Price per Share
$xx.xx
Shares Outstanding
7,126,806
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Echo Health Ventures, Meritech Capital Partners
03/08/2017 Series B-1 $45.25MM $xx.xx $207.68MM Biomatics Capital, GV, Maryland Venture Fund, Venrock, McKesson Ventures, ARCH Venture Partners
Price per Share
$xx.xx
Shares Outstanding
8,262,765
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Biomatics Capital, GV, Maryland Venture Fund, Venrock, McKesson Ventures, ARCH Venture Partners
06/15/2015 Series B $30.25MM $xx.xx $135.88MM ARCH Venture Partners
Price per Share
$xx.xx
Shares Outstanding
5,954,491
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
ARCH Venture Partners
06/18/2014 Series A $5.04MM $xx.xx $16.79MM Venrock
Price per Share
$xx.xx
Shares Outstanding
4,744,293
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Venrock

Aledade investors also invested in these private companies

California Medical Association
Maryland Venture Fund
Lightspeed Venture Partners
Biomatics Capital

Leadership & Board

Leadership

Mandy Cohen
Executive Vice President & Chief Executive Officer, Aledade Care Solutions
Farzad Mostashari MD
Co-Founder & Chief Executive Officer
Mat Kendall
Co-Founder & President
Douglas Street
Chief Operating Officer of Aledade Care Solutions & Chief of Staff
Ritwik Tewari
Chief Technology Officer
Phuong Phillips
Chief Legal Officer
Ahmed Haque
Chief Performance Officer
Nick Kinkaid
Chief Product Officer
Ananya Banerjee
Chief Commercial Officer
Emily Maxson MD
Chief Medical Officer
John Doyle
Chief Financial Officer
Dan Bowles
Chief Growth Officer
Sean Cavanaugh
Chief Policy Officer

Board

Julie Sunderland
Biomatics Capital
Robert Kocher MD
Venrock

Aledade stock FAQs

plusminus

Can you buy Aledade stock?

As Aledade is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Aledade, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
plusminus

How to buy Aledade stock?

To invest in a private company like Aledade through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Aledade stock?

Yes, you may sell the Aledade stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Aledade stock?

If you hold private company shares of Aledade – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Aledade on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is Aledade a public company?

No, Aledade is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Aledade’s stock price?

Aledade is a privately held company and therefore does not have a public stock price. However, you may access Aledade private market stock price with Forge Data.
plusminus

What is Aledade’s stock ticker symbol?

Aledade does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Aledade’s news and media highlights

When we first met Aledade, co-founder and CEO Dr. Farzad Mostashari invited us to learn about the company, but also left us with a polite, albeit straightforward warning: this is a complex business, and we’d have to put in the work to understand the opportunity. We’re glad we accepted the challenge, and we are excited to lead Aledade’s $260M Series F financing round.
Aledade, a company that helps US doctors adapt their practices to new payment arrangements aimed at improving care and cutting costs, raised $260 million in venture capital to expand its network. The deal values the company at $3.5 billion, according to people familiar with the situation, with investors buying in on similar terms to the company’s most recent funding round last year.
Aledade, the nation’s largest network of independent primary care, and Humana Inc. (NYSE: HUM), leading health insurer and health care services company, have announced a 10-year collaboration to provide value-based primary care for Humana’s Medicare Advantage members from in-network Aledade-enabled physicians.
Aledade, a Bethesda, Md.-based company enabling doctors to control health care, closed a $100m Series D funding round
Updated on: Nov 10, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.